Large-quantity testing solutions for organizations of all types and sizes

Boomerang plays an essential role in keeping employees safe and business moving forward. If your organization is looking for large quantity testing solutions, Boomerang can help.

Partner with Boomerang

Comprehensive

One end-to-end solution to manage the complete testing process for your staff

Trusted

Our labs are CLIA-certified and CAP-accredited and our digital platform is HIPAA-compliant

Easy & Painless

We can oboard companies of any size and quickly integrate your employees into one easily managed system

Reviewed & Verified

Our results are thoroughly verified by a medical professional before delivery to ensure accurate reporting

Some of our clients

Partner with Boomerang

Boomerang's COVID-19 testing solution is unmatched

COVID-19 RT-PCR Test Kit

Get tested for COVID-19 conveniently from home.

FREE - $249

Learn more

COVID-19 Antigen Test

Get tested for COVID-19 conveniently from home.

$25

Learn more

Turnaround Time

We ship quickly and can deliver results as fast as 24 hours after receiving samples back to our lab

Ability to Scale

As a CLIA-certified lab, we have the ability to partner with multiple labs allowing us to meet any demand

Reliable

Boomerang is already being used weekly by school districts, film crews, and large corporations

FOR ORGANIZATIONS ORDERING 500 OR MORE TESTING KITS

Boomerang handles all the details for you

Test registration is simple with Boomerang's online account portal

Organizations receive regular status updates throughout the testing process

Receive individual and aggregated results after each session of testing

Partner with Boomerang today

Partner with Boomerang

NOTES :

This home collection kit has not been FDA cleared or approved.
This home collection kit has been authorized only for the home collection and maintenance of nasal swab specimens as an aid in detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
This home collection kit in combination with the authorized test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.